Copyright
©2011 Baishideng Publishing Group Co.
World J Gastroenterol. Feb 14, 2011; 17(6): 809-816
Published online Feb 14, 2011. doi: 10.3748/wjg.v17.i6.809
Published online Feb 14, 2011. doi: 10.3748/wjg.v17.i6.809
Table 3 Mutations of K-ras codons 12, 13, and 61 DNA detected by pyrosequencing assay
| Wild type (AA) | Point mutation (AA) | No. of mutations (%) | |
| K-ras codon 12 | GGT (Gly) | AGT (Ser) | 2 (1.7) |
| GGT (Gly) | GAT (Asp) | 16 (13.6) | |
| GGT (Gly) | GCT (Ala) | 2 (1.7) | |
| GGT (Gly) | GTT (Val) | 8 (6.8) | |
| K-ras codon 13 | GGC (Gly) | GAC (Asp) | 12 (10.2) |
| K-ras codon 61 | CAA (Gln) | CAT (His) | 1 (0.8) |
- Citation: Shen H, Yuan Y, Hu HG, Zhong X, Ye XX, Li MD, Fang WJ, Zheng S. Clinical significance of K-ras and BRAF mutations in Chinese colorectal cancer patients. World J Gastroenterol 2011; 17(6): 809-816
- URL: https://www.wjgnet.com/1007-9327/full/v17/i6/809.htm
- DOI: https://dx.doi.org/10.3748/wjg.v17.i6.809